Author： Sauerland S.
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.23, Iss.5, 2000-11, pp. : 449-461
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefits and Risks of Pharmacotherapy for Dysthymia: A Systematic Appraisal of the Evidence
By De Lima M.S.
Drug Safety, Vol. 26, Iss. 1, 2003-01 ,pp. :
Access to resources
Recommend
High-dose IV methylprednisolone therapy effectively treated haemangioendothelioma
Inpharma, Vol. 1, Iss. 1283, 2001-01 ,pp. :
Kidney Transplantation in Older Patients: Benefits and Risks
By Rao V.K.
Drugs & Aging, Vol. 19, Iss. 2, 2002-02 ,pp. :
Oral anticoagulants: benefits exceed risks in patients with AF
Inpharma, Vol. 1, Iss. 1366, 2002-01 ,pp. :